John Cooper, MD, PhD

Primary Academic Title

Professor of Cell Biology and Physiology and Interim Chair, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine

Research Interest

Effects of oncogenic transformation on cell motility and the cytoskeleton; cell cycle checkpoints based on the cytoskeleton.

Education

1982: MD, Johns Hopkins University, Baltimore
1983: PhD, cell biology, Johns Hopkins University

Training

1983 - 1984: Postdoctoral fellow, cell biology, Johns Hopkins University, Baltimore
1984 - 1985: Intern, pathology, Washington University, St. Louis
1985 - 1987: Postdoctoral fellow, cell biology, Washington University

Selected Research Publications

Septin and actin contributions to endothelial cell-cell junctions and monolayer integrity.

Kim J, Mooren OL, Onken MD, Cooper JA
Cytoskeleton (Hoboken) 2023

CARMIL3 is important for cell migration and morphogenesis during early development in zebrafish.

Stark BC, Gao Y, Sepich DS, [...] Cooper JA
Dev Biol 2022

Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium.

Onken MD, Blumer KJ, Cooper JA
Mol Biol Cell 2021

Junctional Localization of Septin 2 Is Required for Organization of Junctional Proteins in Static Endothelial Monolayers.

Kim J, Cooper JA
Arterioscler Thromb Vasc Biol 2021

View All Publications

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Equity, Diversity and Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Equity, Diversity and Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Treatment
Clinical
How Siteman is leading the way in personalized brain tumor treatment
If you or a loved one have recently been diagnosed with a brain tumor, you likely feel a great deal of fear and have many questions. The brain is the epicenter of who we are,...
Read The Full Story

How Siteman is leading the way in personalized brain tumor treatment

Cancer Types

The Siteman Approach

Specialized Programs

Siteman Cancer Center expands proton therapy treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Couple honors physician with gift for distinguished professorship

John Cooper, MD, PhD

Primary Academic Title

Research Interest

Education

Training

Selected Research Publications

Contact Information

Contact Information